Radioprotection

In Vivo. 2009 Mar-Apr;23(2):323-36.

Abstract

Over 40% of cancer patients will require radiation therapy during management of their disease. Although radiation therapy improves the survival of a significant number of cancer patients, both acute radiation toxicity (which manifests during a course of clinical radiotherapy or shortly thereafter), and late toxicity (developing months to years after completion of radiotherapy) compromise overall outcomes for successfully treated cancer patients.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • DNA Damage
  • Drug Design
  • Humans
  • Mitochondria / radiation effects
  • Models, Biological
  • Neoplasms / radiotherapy*
  • Radiation Injuries / drug therapy*
  • Radiation Injuries / prevention & control*
  • Radiation, Ionizing
  • Radiotherapy / adverse effects*
  • Radiotherapy Dosage
  • Reactive Oxygen Species
  • Treatment Outcome

Substances

  • Reactive Oxygen Species